下载 Nurse’s Drug Handbook App - v3.5.24

应用和NYP, Inject App, MCQ Abubakr (ASU), Pacify, Medical PG, FMGE Preparation - PrepLadder, Jan Aushadhi Sugam (BPPI)一样好，Nurse’s Drug Handbook App - v3.5.24也很多，是类型医疗中最出色的应用之一。

由Skyscape Medpresso Inc开发，Nurse’s Drug Handbook App - v3.5.24至少需要Android版本Android 5.0+。因此，如有必要，您必须更新手机。

Nurse’s Drug Handbook App - v3.5.24 APK的最新版本为3.5.24，发行日期为2021-08-06，大小为10.2 MB。

有关1000下载的统计信息可从Google Play获得。您可以根据需要更新已单独下载或安装在Android设备上的应用。更新您的应用可以为您提供更多功能。您可以访问最新功能并提高安全性和应用程序的稳定性。

由于并非所有游戏或应用程序都兼容所有手机。并且游戏或应用程序不适用于您的设备，因此取决于Android OS版本，屏幕分辨率或Google Play允许访问的国家/地区。因此，通过APK4Share，您可以轻松下载APK文件，不受这些限制。

The most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z.

DESCRIPTION
The Jones & Bartlett Learning 2020 Nurse’s Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a no-nonsense style that speaks your language in terms you use every day, it offers concise and consistently formatted drug entries organized alphabetically.

The 2020 Nurse is Drug Handbook,

Key Features:

- Index of all generic, trade, and alternate drug names
- Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule
- Indications and dosages, as well as route, onset, peak, and duration information
- Incompatibilities and contraindications
- Interactions with drugs, food, and activities
- Adverse reactions
- Nursing considerations, including key teaching points for patients
- Mechanism-of-action illustrations
- Warnings and precautions
- Updated antineoplastic drug therapy appendix
- Addition of bolded Life-Threatening Adverse Reactions (ADRs)

NEW TO THIS EDITION
New drugs added to the 2020 Nurse's Drug Handbook include: PEGlated-auci jivi, baloxavir marboxil, baricitinib, inactivated-zhzo, didanosine, doravirine, Eravacycline, erenumab-aooe, fremanezumab-vfrm, frovatriptan, galcanezumab-gnlm, ganiciclovir, ibalizumab-uiyk, lofexidine, lubiprostone, omadacycline, plazomicin, revefenacin, rifamycin, saquinavir, sarecycline, semaglutide, sodium zirconium cyclosilicate, sufentanil, tildrakizumab-asmn

UI/UX & Performance Enhancements